We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Equifax
EFX
$20.5B
| $382K | ﹤0.01% |
+1,473
| New | +$375K |
|
|
JCAP
877
Jefferson Capital
JCAP
$1.27B
| $369K | ﹤0.01% |
+20,000
| New | +$373K |
|
|
SLN
878
Silence Therapeutics
SLN
$504M
| $362K | ﹤0.01% |
62,459
-72,033
| -54% | -$309K |
|
|
INGM
879
Ingram Micro Holding
INGM
$6.44B
| $360K | ﹤0.01% |
17,284
| – | – |
|
880
Datadog
DDOG
$97.4B
| $357K | ﹤0.01% |
2,654
-57,058
| -96% | -$6.32M |
|
881
Savara
SVRA
$1.09B
| $355K | ﹤0.01% |
155,860
-96,052
| -38% | -$261K |
|
882
Agilysys
AGYS
$3.09B
| $352K | ﹤0.01% |
+3,068
| New | +$277K |
|
883
Blackbaud
BLKB
$2.01B
| $339K | ﹤0.01% |
+5,286
| New | +$330K |
|
|
MLNK
884
DELISTED
MeridianLink
MLNK
| $336K | ﹤0.01% |
20,694
+2,069
| +11% | +$34.6K |
|
885
Vertex
VERX
$2.17B
| $335K | ﹤0.01% |
+9,470
| New | +$360K |
|
886
HubSpot
HUBS
$12.3B
| $331K | ﹤0.01% |
595
-710
| -54% | -$416K |
|
887
Asana
ASAN
$1.97B
| $324K | ﹤0.01% |
24,015
-664,698
| -97% | -$10.4M |
|
|
PRO
888
DELISTED
PROS Holdings
PRO
| $322K | ﹤0.01% |
20,535
+5,690
| +38% | +$96.9K |
|
889
Under Armour
UAA
$2.89B
| $321K | ﹤0.01% |
47,044
-200,610
| -81% | -$1.25M |
|
|
CFLT
890
DELISTED
Confluent
CFLT
| $321K | ﹤0.01% |
12,884
-1,264
| -9% | -$28.5K |
|
|
DOCU
891
DocuSign
DOCU
$10.5B
| $305K | ﹤0.01% |
+3,912
| New | +$316K |
|
892
Axcelis
ACLS
$4.03B
| $290K | ﹤0.01% |
+4,159
| New | +$237K |
|
893
Fastly Inc
FSLY
$3.6B
| $275K | ﹤0.01% |
+38,981
| New | +$261K |
|
894
FIVE9
FIVN
$2.22B
| $264K | ﹤0.01% |
9,980
-3,687
| -27% | -$96K |
|
895
Teradata
TDC
$3.02B
| $257K | ﹤0.01% |
+11,527
| New | +$251K |
|
896
Dropbox
DBX
$7.71B
| $246K | ﹤0.01% |
+8,590
| New | +$243K |
|
897
DoubleVerify
DV
$1.8B
| $241K | ﹤0.01% |
16,069
-14,756
| -48% | -$202K |
|
898
PagerDuty
PD
$856M
| $239K | ﹤0.01% |
15,617
-14,833
| -49% | -$230K |
|
899
SiTime
SITM
$16.5B
| $235K | ﹤0.01% |
+1,101
| New | +$199K |
|
900
Ziff Davis
ZD
$1.99B
| $232K | ﹤0.01% |
+7,654
| New | +$246K |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.